Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ConvaTec ( (GB:CTEC) ) has issued an announcement.
ConvaTec Group PLC has executed a share buyback program, purchasing 1,380,495 ordinary shares at prices ranging from 235.00 to 237.20 pence per share, with an average price of 236.03 pence. This move is part of a larger $300 million buyback initiative announced in August 2025, aimed at optimizing the company’s capital structure and potentially enhancing shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £260.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s overall stock score is driven primarily by its strong financial performance, which is offset by a cautious technical outlook and a relatively high valuation. The company’s robust financial health and effective cash flow management are significant strengths. However, the lack of positive technical indicators and a high P/E ratio suggest potential risks in the current market environment.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products and technologies industry, focusing on providing solutions for advanced wound care, ostomy care, continence and critical care, and infusion care. The company is known for its innovative products that cater to healthcare professionals and patients worldwide.
Average Trading Volume: 7,764,749
Technical Sentiment Signal: Hold
Current Market Cap: £4.78B
Learn more about CTEC stock on TipRanks’ Stock Analysis page.